Vireo Growth (VREOF) Revenue (2020 - 2026)
Vireo Growth's (VREOF) quarterly Revenue came in at $106.2 million in Q1 2026, up 333.47% year-on-year from $24.5 million in Q1 2025, and up 1.62% quarter-over-quarter from $104.5 million in Q4 2025.
Vireo Growth (VREOF) Revenue (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Revenue across 7 years of filings, most recently posting $106.2 million for Q1 2026.
- Revenue for Q1 2026 came in at $106.2 million, up 333.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $350.4 million (up 251.14% YoY), and the FY2025 annual result was $268.8 million, up 170.43% from the prior year.
- Revenue came in at $106.2 million for Q1 2026 at Vireo Growth, up from $104.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $106.2 million in Q1 2026 to a low of $15.6 million in Q1 2022.
- The 5-year median for Revenue is $24.5 million (2025), against an average of $37.5 million.
- Across the five-year window, Revenue slipped 4.24% in 2023 and jumped 333.47% in 2026, its largest moves.
- Vireo Growth's Revenue stood at $19.0 million in 2022, then climbed by 26.94% to $24.2 million in 2023, then increased by 3.52% to $25.0 million in 2024, then jumped by 317.65% to $104.5 million in 2025, then climbed by 1.62% to $106.2 million in 2026.
- The last three Revenue figures came in at $106.2 million (Q1 2026), $104.5 million (Q4 2025), and $91.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 608.10 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 377.33 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 106.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.20 Mn |
| Dec 31, 2025 | 104.51 Mn |
| Sep 30, 2025 | 91.66 Mn |
| Jun 30, 2025 | 48.06 Mn |
| Mar 31, 2025 | 24.50 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 25.17 Mn |
| Jun 30, 2024 | 25.11 Mn |
| Mar 31, 2024 | 24.09 Mn |
| Dec 31, 2023 | 24.17 Mn |
| Sep 30, 2023 | 24.68 Mn |
| Jun 30, 2023 | 20.20 Mn |
| Mar 31, 2023 | 19.09 Mn |
| Dec 31, 2022 | 19.04 Mn |
| Sep 30, 2022 | 18.85 Mn |
| Jun 30, 2022 | 21.09 Mn |
| Mar 31, 2022 | 15.64 Mn |
| Dec 31, 2021 | 13.66 Mn |
| Sep 30, 2021 | 13.37 Mn |
| Jun 30, 2021 | 14.23 Mn |